A new study was introduced online International Drug Policy Journal (which will appear in the September 2023 issue of the Journal) provides evidence that states where medical marijuana is legal have lowered health insurance premiums.
Study authors, including professors from Bowling Green State University in Ohio, Illinois State University, and Eastern Michigan University, used U.S. private health insurance financial data collected by the National Association of Insurance Commissioners from 2010 to 2021. investigated. The steepest cuts were seen in medical cannabis states after seven years, with annual premiums set at $1,662.70, followed by $1.541.80 in the eighth year and $1,625.80 in the ninth year. “The medical marijuana law will not take effect until seven years after its enactment, but it will significantly reduce health insurance premiums.” the authors said.
Ultimately, the researchers noted, these savings were “appreciated by cannabis users and non-users alike in states that have introduced MCL.” [medical cannabis laws]”
The study included a survey of individual market health insurance plans, but not employer-provided insurance. We also analyzed only data from states with only medical cannabis, excluding medical and adult cannabis.
“The introduction of the MCL will lower health insurance premiums for the individual market. Health insurance spending, including premiums, accounts for 16% to 34% of US households. Findings show that households with health insurance in the individual (i.e., non-employer-assisted) market in states with MCL appreciate significantly lower premiums. suggesting.”
The study authors also noted that premiums vary depending on when states enact medical marijuana laws. “Early-, mid-, or late-adopting states appear to see slightly higher premiums in the full two years of enactment,” the researchers explained. “However, early adopter states continue to see premium declines from years 3 through 9, while mid-adopter states see a waning impact on premiums from year 3 onwards. I understand this.”
While some have suggested that legalizing medical marijuana would raise health insurance premiums, the researchers in the study suggest those claims are false and lack evidence.
The theme of reduction applies equally to other studies, ranging from reducing the risk and symptoms of specific medical conditions to reducing the impact of legal cannabis in cities and areas of the state.
The topic of youth cannabis use has led to many studies on its risks and benefits, but some studies, such as a study published by the University of Illinois, found that young people living in zip codes with medical cannabis dispensaries , found that they consumed less cannabis than young people who did not live there. Near a medical cannabis dispensary.
Cannabis can also help people with chronic pain improve their quality of life and reduce opioid use, according to a study published in April that analyzed more than 700 chronic pain patients enrolled in the UK Medical Cannabis Registry. found. Another study found that four out of five patient participants also reduced or stopped using opioids entirely because of cannabis consumption. Israeli researchers reached similar conclusions when analyzing pain and opiate dependence in cancer patients. Additionally, other studies have explored trends in legalizing prescription drugs to treat conditions such as pain, depression, anxiety, sleep, psychosis, and seizures.
Some of the most powerful examples of cannabis alleviating medical conditions are seen in people suffering from epileptic seizures. One study found that whole cannabis extract helped reduce seizures by 86%.
A study published earlier this month found that cannabis users have a reduced risk of type 2 diabetes, but further studies are recommended to further explore the evidence. Other studies have also found that cannabis is associated with a lower risk of liver disease, lower blood pressure, and less fatigue.